Expression of latent membrane proteins in Epstein-Barr virus-transformed lymphocytes in vitro

11Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Infection with Epstein-Barr virus (EBV) induces activation and proliferation of B lymphocytes. Detection of latent membrane protein (LMP)-1 is used to identify the proliferative ability of B cells. However, changes in the expression levels of the three LMPs during EBV-induced B lymphocyte transformation, have not yet been reported. In the present study, the expression levels of LMP-1, LMP-2A and LMP-2B were compared between EBV-transformed B lymphocytes and paired normal lymphocytes. Seven lymphoblast cell lines were established by EBV infection of normal human lymphocytes in vitro. The expression levels of LMP genes and LMP-1 protein were determined using quantitative (q)PCR and western blotting in lymphoblasts and normal lymphocytes, respectively. The expression of LMP1, LMP-2A and LMP-2B genes was significantly upregulated in EBV-induced lymphoblasts compared with the normal lymphocytes. The LMP-1 protein level was also significantly increased in EBV-transformed B lymphocytes. Expression of LMP1, LMP-2A and LMP-2B genes was significantly upregulated in EBV-induced lymphoblasts, suggesting LMP genes are important in the transformation of human lymphocytes.

Cite

CITATION STYLE

APA

Tang, Y., Luo, C., Cheng, A., Lu, S., Xu, J., Fu, T., & Gan, R. (2014). Expression of latent membrane proteins in Epstein-Barr virus-transformed lymphocytes in vitro. Molecular Medicine Reports, 10(2), 1117–1121. https://doi.org/10.3892/mmr.2014.2313

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free